News

Targeted Oncology4h
Phase 1 Trial of JBZ-001 Targets Solid Tumors and Non-Hodgkin Lymphoma
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
Targeted Oncology18h
The Evolving Role of ctDNA in Colorectal Cancer: Updates from ASCO 2025
Anita Turk, MD, discusses abstracts from ASCO 2025 highlight the evolving role of ctDNA in the management of colorectal ...
Targeted Oncology19h
Dr Turk on the Biggest Takeaways in GI Cancer from ASCO 2025
Anita Turk, MD, details her biggest takeaways from the 2025 ASCO Annual Meeting in gastrointestinal cancers. Anita Turk, MD, medical oncologist at IU Health, discusses her biggest takeaways in the ...
Targeted Oncology20h
Long-Term Data Validates IsoPSA for Prostate Cancer Risk Stratification
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
Targeted Oncology21h
TAR-200 Offers New Hope for BCG-Unresponsive Bladder Cancer
Joseph Jacob, MD, discusses the promising impact of TAR-200.
Targeted Oncology22h
Dr Jimenez Jimenez on Increasing Transplant Access Through Mismatch Donors
Antonio Jimenez Jimenez, MD, discusses the ACCESS trial of PTCy-based GVHD prophylaxis after mismatched unrelated donor stem ...
Targeted Oncology23h
Dr Klempner Highlights Practice-Changing Role of Durvalumab/FLOT in Gastric Cancer
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...